HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency

Autor:	Chris M. Bacon, Mary Slatter, Ajay Vora, Kieran McHugh, Attilio Rovelli, Simon Bomken, Sujith Samarasinghe, Kevin Windebank, Giulia Prunotto, Claire Gowdy, Paul Veys, Robert Wynn, Giovanna Lucchini, Ugonna T. Offor, Andrew R. Gennery, Ben Carpenter
Rok vydání:	2020
Předmět:	Male 0301 basic medicine Pediatrics medicine.medical_specialty Adolescent Primary Immunodeficiency Diseases Immunology MEDLINE Lymphoproliferative disorders National cohort 03 medical and health sciences 0302 clinical medicine hemic and lymphatic diseases medicine Humans Immunology and Allergy Effective treatment Child business.industry Hematopoietic Stem Cell Transplantation Infant medicine.disease Lymphoproliferative Disorders Treatment Outcome surgical procedures operative 030104 developmental biology Child Preschool Primary immunodeficiency Female business therapeutics 030215 immunology
Zdroj:	Journal of Allergy and Clinical Immunology. 146:447-450
ISSN:	0091-6749
Popis:	Summary In a national cohort, we demonstrate the safety and efficacy of tailored chemo-immunotherapy followed by RIC HSCT for PID-associated lymphoproliferative disorders in children.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed8c8c883b7065e299a4f0d7f3e007c https://doi.org/10.1016/j.jaci.2020.03.043 Zobrazit plný text záznamu Full Text from ScienceDirect